Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice
Objective: To examine if actual clinical practice of antipsychotic use in Parkinson's Disease patients are consistent with published evidence-based reviews of treatment recommendations and discuss…Minor hallucinations in Parkinson’s disease: neuropshycological and neurophysiological correlates in a representative sample of non-demented patients.
Objective: To study the neuropsychological and neurophysiological correlates of minor hallucinations (mH) in non-demented PD patients, by using different scales and the event-related potentials (ERP)…What do patients with Parkinson’s disease see in their hallucinations? Classification of hallucinations which are seen in Parkinson’s Disease; Single Center Experience
Objective: Our purpose is to evaluate and classify visiual hallucination of 52 patients with Parkinson' s Disease and to detect if there is any relation between…A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations
Objective: To evaluate the safety and efficacy of nelotanserin in Lewy body dementia subjects experiencing visual hallucinations. Background: Nelotanserin is a selective 5HT2A receptor inverse…Gender differences in DLB: frequency, clinical presentation and treatment
Objective: To describe demographic and clinical characteristics and use of cholinesterase inhibitors in women and men diagnosed with DLB. Background: DLB seems to be more…Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia
Objective: To observe whether visual hallucinations serve as a predictor of Parkinson's disease dementia. Background: Visual hallucinations (VH) is one of non-motor symptoms in Parkinson's…Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED
Objective: To establish whether frontal cognitive deficits associated with visual hallucinations in Parkinson's disease (PD) are also present in patients with Charles Bonnet Syndrome (CBS).…How many and which kind of Parkinson’s disease patients need deep brain stimulation surgery? An evaluation based on clinical observation of patients with disease history of 15th year or more
Objective: To grasp real demand of deep brain stimulation (DBS) surgery in a substantial Parkinson's disease (PD) population. Background: DBS surgery has become frequently performed…Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis
Objective: To examine the accuracy, effectiveness, and utility of a novel virtual reality (VR) simulation representing symptoms of Parkinson's disease psychosis (PDP). Background: Diagnosing PDP…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- Next Page »